Physician profile
Ali Krisht
NPI 1043300528
$15,003.68
in general payments reported to CMS, 2019-2025
9 companies · $36.37 in 2025
The $36.37 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $198 · 2021: $611 · 2022: $408 · 2023: $14K · 2025: $36.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,500 · Travel and Lodging: $4,091 · Food and Beverage: $67.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,500.00 |
| Travel and Lodging | $4,090.52 |
| Food and Beverage | $67.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $14,125.63 | 2021-2023 | Integra, Omnigraft, Primatrix |
| Stryker Corporation | $500.00 | 2021 | |
| Si-Bone, INC. | $125.24 | 2020 | |
| Zimmer Biomet Holdings, INC. | $113.90 | 2019 | |
| Baxter Healthcare | $53.05 | 2020 | |
| Carl Zeiss Meditec USA, INC. | $36.37 | 2025 | |
| Mallinckrodt Hospital Products INC. | $19.42 | 2020 | |
| Smith+Nephew, INC. | $15.24 | 2019 | |
| Elutia, INC. | $14.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Krisht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.